Clinicopathological Prognostic Factors Determining Outcomes of Treatment in Gastric Cancer Surgery

In Vivo. 2022 Nov-Dec;36(6):2927-2935. doi: 10.21873/invivo.13035.

Abstract

Background/aim: The purpose of this study was to examine the impact of clinicopathological prognostic factors on tumor resectability, perioperative complications, and 5-year survival rates in patients with gastric cancer treated surgically.

Patients and methods: A cohort of 834 patients operated on for gastric cancer between 2007 and 2016 was analyzed.

Results: Patients over 70 years of age manifested a significantly higher rate of overall complications, systemic complications, surgical complications, perioperative mortality, and a worse 5-year survival. The diffuse type according to the Lauren classification was an independent prognostic factor for perioperative mortality. TNM stage significantly influenced resectability and 5-year survival rates. Furthermore, the presence of distant metastases (M1 stage) significantly increased the rates of overall complications, systemic complications, and perioperative mortality.

Conclusion: Although TNM stage was the most important prognostic factor for resectability, perioperative complications and 5-year survival, other clinicopathological prognostic factors, such as age, and Lauren type also significantly affected treatment outcomes in gastric cancer surgery.

Keywords: Gastric cancer surgery; prognostic factors; treatment outcome.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Gastrectomy / adverse effects
  • Humans
  • Neoplasm Staging
  • Prognosis
  • Retrospective Studies
  • Stomach Neoplasms* / diagnosis
  • Stomach Neoplasms* / surgery
  • Survival Rate
  • Treatment Outcome